Å·ÃÀAV

Phishing warning 01-May-2024
We are aware of phishing emails targeting speakers of events whose names appear on our events pages. If you are unsure if an email regarding event registration or accommodation has come from us please contact us and do not provide any credit card details or personal information.

Biotransformations II: Science to Industrial Application

24 March 2023 09:30-17:00, London, United Kingdom


Introduction
The Å·ÃÀAV Biotechnology Group welcomes you to this exciting one-day symposium, a follow-up to a meeting of the same title run in 2017. This second meeting in the series will highlight recent achievements, future challenges and current trends in the use of biotransformations and biocatalysis in the industrial biotechnology sector. The focus is on the discovery, modification and industrial application of novel enzymes for biocatalysis, as well as analytical and process engineering, synthetic biology, computational biology, biochemistry, microbiology, and chemistry, that are being harnessed to deliver new biocatalysts for the synthesis of chemical products.

Confirmed speakers:
We will also be selecting at least two additional early career speakers from our abstract submissions. 

Prof. Don Hilvert: ETH Zurich
High-throughput engineering of biosynthetic assembly lines

Prof. Ross Anderson: Bristol University

Dr. Sarah Barry: Kings College London

Prof. Gideon Grogan: York University
Unspecific Peroxygenases: Expression, Application and Catalytic Promiscuity

Prof. Helen Hailes:  University College London
Enzymatic single-step reactions and the construction of biocatalytic cascades

Dr. Holly Reeve: CEO and Co-founder, HydRegen Limited
Biocatalytic hydrogenation: robust biotechnologies for sustainable chemical manufacturing
Speakers
  • Prof. Don Hilvert ETH Zurich, Switzerland
  • Prof. Ross Anderson Bristol University, United Kingdom
  • Dr. Sarah Barry Kings College London, United Kingdom
  • Prof. Gideon Grogan York University, United Kingdom
  • Prof. Helen Hailes University College London, United Kingdom
  • Dr. Holly Reeve CEO and Co-founder, HydRegen Limited, United Kingdom

Venue
The Å·ÃÀAV

The Å·ÃÀAV, Burlington House, Piccadilly, London, W1J 0BA, United Kingdom

Useful links

Committee
Organised by
Prof Paul A. Dalby (University College London: p.dalby@ucl.ac.uk), Prof Paul Race (University of Bristol), Dr Stephen Wrigley (Hypha Discovery Ltd), and Dr. Colin Bedford (University College London), under the auspices of the Å·ÃÀAV Biotechnology Interest Group.

The Biotechnology Group is the focal point within the Å·ÃÀAV for members who have an academic or industrial interest in the chemical aspects of biotechnology.

The Group has annually run conferences or symposia on a diverse range of topics, including Biotransformations, Natural Products, Stem Cell Therapies, Neurological Disorders, Proteomics, and Glycomics. 
Contact information
Search
 
 
Showing all upcoming events
Start Date
End Date
Location
Subject area
Event type

Advertisement
Spotlight


E-mail Enquiry
*
*
*
*